Moderate Oxidative Stress and High Antioxidative Activity Are Associated with Steatosis in Japanese Males

Clinical and Translational Science

Volumn 6, Issue 1, 2013, Pages 45-49

  Imatoh, Takuya ^a   Kamimura, Seiichirou ^b   Tanihara, Shinichi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Division of preventive medicine   (Japan)

Author keywords

Epidemiology; Liver disease; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ECHOGRAPHY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OXIDATIVE STRESS; PRIORITY JOURNAL; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ANTIOXIDANTS; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; FATTY LIVER; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; ODDS RATIO; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84873701741     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/cts.12007     Document Type: Article

References (20)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
2. Miura Y, Endo T. Survival responses to oxidative stress and aging. Geriatr Gerontol Int. 2010; 10: S1-S9.
3. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114: 1752-1761.
4. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-140.
5. Gastaldelli A, Kozakova M, Hojlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B. RISC investigators: fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009; 49: 1537-1544.
6. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845.
7. Riquelme A, Arrese M, Soza A, Morales A, Baudrand R, Pérez-Ayuso RM, Gonzalez R, Alvarez M, Hernandez V, Garcia-Zattera MJ, et al. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum concentrations of C-reactive protein in Hispanics. Liver Int. 2009; 29: 82-88.
8. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, Zoli M, Marchesini G. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42: 473-480.
9. Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med. 2005; 22: 1354-1358.
10. Bae JC, Cho YK, Lee WY, Seo HI, Rhee EJ, Park SE, Park CY, Oh KW, Kim BI. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c concentrations in nondiabetic subjects. Am J Gastroenterol. 2010; 105: 2389-2395.
11. Bajaj S, Nigam P, Luthra A, Pandey RM, Kondal D, Bhatt SP, Wasir JS, Misra A. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease. Indian J Med Res. 2009; 129: 285-292.
12. Bonnefont-Rousselot D, Ratziu V, Giral P, Charlotte F, Beucler I, Poynard T. Blood oxidative stress markers are unreliable markers of hepatic steatosis. Aliment Pharmacol Ther. 2006; 23: 91-98.
13. Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol. 2006; 40: 930-935.
14. Narasimhan S, Gokulakrishnan K, Sampathkumar R, Farooq S, Ravikumar R, Mohan V, Balasubramanyam M. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin Biochem. 2010; 43: 815-821.
15. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996; 239: 70-76.
16. Perez M, Gonzales L, Olarte R, Rodriguez NI, Tabares M, Salazar JP, Jaimes S, Garcia RG, Lopez-Jaramillo P. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population. Prev Med. 2011; 52: 174-177.
17. Chiang CH, Huang CC, Chan WL, Chen JW, Leu HB. The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population. Clin Biochem. 2010; 43: 1399-1404.
18. Alberti A, Macciantelli D, Carratelli M. The radical cation of N, N-diethyl-para-phenilendi-amine: a possible indicator of oxidative stress in biological samples. Res Chem Intermed. 2000; 26: 253-267.
19. Honda Y, Tanaka M, Honda S. Redox regulation, gene expression and longevity. Geriatr Gerontol Int. 2010; 10: S59-S69.
20. Irie M, Asami S, Nagata S, Miyata M, Kasai H. Relationships between perceived workload, stress and oxidative DNA damage. Int Arch Occup Environ Health 2001; 74: 153-157.